UUID262FF996A-9C3E-4E29-BDS7-10CC282R5CéScBI7a
TCGA- YL-A A-BSH 61A- PR

I IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII||II||IIIIIIIIeIICIIIIIlcllmI
I IIIIIII IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII
I IIIIIIIIIIIIIIIIIIIIIIIIIII|IIIIIIIIIIIIIII|I|IIIIII||III|I|

PROSTATE_A_ND PE_LVIC/OBTURATOR LYMPH NODEs- RADICAL PROSTATECTOMY:
TUMOR PROCUREMENT: _
HISTOLOGIC TYPE
ACINAR ADENOCARCINOMA
HISTOLOGIC GRADE (PRIMARY PATTERN+SECONDARY PATTERN = GLEASON SCORE):
4 + 3 = 7
PERCENTAGE OF DIFFERENT GLEASON PATTERNS Q/W : 4 AL/ ,wu
3:_2o% 0w“ ' ,
4:_3o% 4X MW 5‘ ' '
TUMOR LOCATION
APEX
MID
BASE
ANTERIOR
RIGHT
POSTERIOR V ,
RIGHT 16’ 4D 0 - 5
LEFT
EXTRA-PROSTATIC EXTENSION adwa, (/ﬂmé,,Léy1/gr:j A105 8“ 0/ 3
PRESENT

NON-FOCAL _ W (/10 / 5?
SITE 0F EXTRA-PROSTATIC EXTENSION 6J1 3 WAR) {3&7 A) J

APEX

29,125 9% ’5 "AG/’2"

ANTERIOR
RIGHT
POSTERIOR
RIGHT
SEMINAL VESICAL INVASION
ABSENT
SURGICAL MARGINS
FREE OF INVASIVE CARCINOMA
LYMPHOVASCULAR INVASION
ABSENT
PERINEURAL INVASION
ABSENT
TUMOR VOLUME
PROPORTION OF PROSTATE INVOLVED BY CARCINOMA: _40-50%
TREATMENT EFFECT ON CARCINOMA
NOT APPLICABLE
LYMPH NODES
RIGHT PELVIC
NUMBER OF NODES INDENTIFIED: _12_
NUMBER OF NODES INVOLVED BY METASTASIS: _0_
LEFT PELVIC
NUMBER OF NODES INDENTIFIED: _6__
NUMBER OF NODES INVOLVED BY METASTASIS: _0_
RIGHT PARAVESICAL
NUMBER OF NODES IDENTIFIED: _1_
NUMBER OF NODES INVOLVED BY METASTASIS: _0_
LEFT PARAVESICAL
NUMBER OF NODES IDENTIFIED: _2_
NUMBER OF NODES INVOLVED BY METASTASIS: _O_

 

 

ADDITIONAL PATHOLOGIC FINDINGS
HIGH-GRADE PROSTATIC INTRA-EPITHELIAL NEOPLASIA
NODULAR HYPERPLASIA
PATHOLOGICAL STAGING
pT3a
pNO
pMX

 

 

TCGA Pathologic Diagnosis Discrepancy Form

 

 

 

 

 

him The TCGA Pathologic Diagnosis Discrepancy Form should be completed when the pathologic diagnosis
documented on the initial pathology report for a case submitted for TCGA is inconsistent with the diagnosis provided on the
Case Quality Control Form completed for the submitted case.

 

 

 

Tissue Source Site USS): _ ___‘l‘SS identiﬁer: TSS Unique Patient Identiﬁer:
Completed By (Interviewer Name on Openc'llnica): _ “Completed Date: _

 

Diagnosis Information

 

 

 

it Data Element Entry Alternatives Working Instructions
Provide the diagnosis] hlstologiI: subtype(s) documented on
Pathologic Diagnosis ‘ ,- , , -. P the initial pathology report for this case. lithe histology for
1 Provided on I nitiaI ﬂL—A—M‘a’ 9 80¢ AMA/14 this case is mixed. provide all listed subtypes.
Pathology Report éiﬁﬂ-mb/ ~‘tl'fd 5:77
. . Provide the histologic features selected on the TCGA Case
Histologic features of . .
,.‘ , ., .. . ualI Conitroliorm com leted [or this use.
2 the sample provided r3161 N452 4&MC410NOW Q (y p L
for TCGA as reﬂected - ,1 I -
. «(tﬂf “Li .‘7/rt/.¢
on the CQCF. C L ‘6

 

 

 

Discrepancy between Pathology Report and Case Quality Control Form

 

3 Provide the reason for Provide a reason describing why the diagnosis on the initial
- . holo re on for this case is not consistent With the
the discrepancy PF“ 81' i)
v ‘* - .. din nosis selected on the TCGA Case ualit Control Form.
between the pathology Fiﬁ/X43232) Walt: g Q y
report and the 'I‘CGA
inanuahty Control Can/713.057) MW Iz’ﬂ'RﬂJA/ 1L

(WWUNG' i'sszaf)

 

Name of 'l'SS Reviewing PrOVIde the name of the pathologist who reviewed this case
4 Pathologist or f‘” TCGA’
Biorepository Director

 

 

 

 

 

 

I acknowledge that the above Informuuon provided by my Institution is true and correct and has been quality controlled.

 

TSS Reviewing Pathologist or Biorepository Director ‘ Date

I acknowledge that the above information provided by my institution is true and correct and has been quality controlled. The Attending Pathologist or the
Department Chairman has been informed or ls aware of the above discrepancy In diagnoses.

 

 

Principﬁl Investigator Signature Date

